Fibromyalgia: symptoms, overlapping conditions and biomarkers worth checking

Central sensitisation and pain processing

Fibromyalgia is understood primarily as a disorder of central pain processing. In people with fibromyalgia, the central nervous system amplifies pain signals, a mechanism called central sensitisation, meaning that stimuli that would be mildly uncomfortable or unnoticed in most people are experienced as significantly painful. This explains why fibromyalgia pain is widespread rather than localised, and why it affects multiple body regions simultaneously. The underlying neurobiology involves altered activity in descending pain modulation pathways and changes in how the brain processes sensory input.

Hypothyroidism as a key mimic

Hypothyroidism and fibromyalgia share a remarkably similar symptom profile: widespread muscle pain, persistent fatigue, cognitive slowing, poor sleep quality, weight changes, and low mood. This overlap is clinically significant because a meaningful proportion of people presenting with fibromyalgia-like symptoms will, on investigation, have undiagnosed hypothyroidism or subclinical thyroid dysfunction. Thyroid function testing, including TSH and Free T4, is recommended as a standard part of the diagnostic workup for all people with suspected fibromyalgia. Identifying hypothyroidism matters because it is treatable, and effective thyroid management can resolve a significant portion of the symptom burden.

Vitamin D deficiency and musculoskeletal pain

Low vitamin D status is associated with musculoskeletal pain, muscle weakness, and fatigue that can closely resemble fibromyalgia. Studies of people diagnosed with fibromyalgia consistently find higher rates of vitamin D deficiency than in matched controls. In a retrospective analysis of over 2,000 patients with fibromyalgia, 42.4% had vitamin B12 deficiency below 400 ng/L, and fatigue and memory loss were significantly more common in the deficient group. Low vitamin D and low B12 can each independently produce a symptom pattern that, in the absence of testing, might be attributed to fibromyalgia rather than a correctable deficiency.

Iron deficiency and ferritin status

Iron deficiency is very common in people with fibromyalgia and can cause or worsen fatigue, poor sleep, and depressive symptoms independently of whether fibromyalgia is present. Ferritin, the marker of stored iron, can be low even when haemoglobin is normal, meaning that standard anaemia screens may miss iron-depleted individuals who are nonetheless experiencing the functional effects of insufficient iron. Restless leg syndrome, which is associated with fibromyalgia, is also strongly linked to low ferritin status, making this a clinically significant biomarker to check in anyone presenting with the fibromyalgia symptom cluster.

Inflammatory arthritis and autoimmune conditions

Rheumatoid arthritis, lupus, Sjogren's syndrome, and other inflammatory rheumatic diseases can produce widespread pain, fatigue, and cognitive symptoms that overlap significantly with fibromyalgia. A key distinguishing feature is the presence of inflammatory markers (elevated CRP or ESR) and specific autoimmune antibodies. Normal inflammatory markers, alongside a pattern of widespread pain without joint swelling or structural damage, generally support a fibromyalgia diagnosis rather than inflammatory arthritis. However, fibromyalgia and inflammatory rheumatic disease can coexist, and the presence of one does not exclude the other.

Sleep disruption and the fibromyalgia-sleep cycle

Poor sleep quality is both a symptom and a driver of fibromyalgia. People with fibromyalgia are frequently found to have disrupted slow-wave (deep) sleep, during which pain thresholds are normally restored and cellular repair occurs. The disruption of this sleep architecture perpetuates the central sensitisation pattern, increases pain sensitivity the following day, and contributes to the fatigue and cognitive symptoms that accompany the pain. Conditions that disrupt sleep independently, including sleep apnoea, restless leg syndrome, and circadian rhythm disruption, can worsen fibromyalgia significantly, and assessing these overlapping contributors is part of a comprehensive approach.

There is no blood test that diagnoses fibromyalgia. The diagnosis is clinical, based on the pattern and duration of symptoms assessed against the American College of Rheumatology 2016 criteria, which evaluate widespread pain index and symptom severity score. Blood testing serves a different but equally important purpose: ruling out conditions with overlapping symptoms that are treatable, and identifying deficiencies that may be causing or significantly worsening the symptom pattern.

The recommended baseline workup for suspected fibromyalgia includes full blood count, thyroid function (TSH and Free T4), ferritin and iron studies, vitamin D, vitamin B12, and inflammatory markers (CRP or ESR). This panel identifies hypothyroidism, vitamin deficiencies, iron deficiency, and inflammatory conditions, each of which can produce a symptom pattern that mimics or worsens fibromyalgia.

If your inflammatory markers are elevated (suggesting a process beyond fibromyalgia is active), or if you have joint swelling, rashes, or other signs that suggest inflammatory arthritis or an autoimmune condition, your GP should be involved for further specialist investigation. Fibromyalgia is a clinical diagnosis made after other conditions have been considered and ruled out through appropriate assessment.

Sleep quality as a primary lever

Because disrupted slow-wave sleep both reflects and perpetuates central sensitisation, improving sleep architecture has direct effects on fibromyalgia symptom severity. Consistent sleep timing, darkness during sleep, avoiding alcohol (which fragments sleep architecture even when it initially promotes drowsiness), and assessing for sleep apnoea, which may require a specialist referral, are the most impactful sleep interventions. Low-dose amitriptyline and similar medications prescribed by GPs are specifically intended to restore slow-wave sleep architecture in fibromyalgia, rather than to act primarily as antidepressants.

Graduated movement and pacing

Regular low-to-moderate intensity physical activity consistently reduces fibromyalgia symptom severity, including pain intensity, fatigue, and cognitive function, in randomised controlled trials. The challenge is pacing: overexertion on better days, followed by significant flares, is a common pattern that worsens the overall trajectory. Graduated aerobic activity, starting at very low intensity and increasing slowly over weeks, is the evidence-based approach. Activities like walking, swimming, and cycling tend to be better tolerated than high-impact exercise.

Addressing nutrient deficiencies

Correcting identified deficiencies, particularly vitamin D, B12, and ferritin, should be a first step before pursuing more complex symptom management approaches. Vitamin D supplementation in deficient individuals improves musculoskeletal pain and may reduce fatigue. B12 repletion in deficient individuals is associated with improvements in cognitive symptoms and fatigue. Iron supplementation in those with low ferritin addresses restless leg syndrome and reduces fatigue. Tracking these biomarkers before and after supplementation gives measurable confirmation that levels are improving.

Gut health and the microbiome connection

A growing body of research links gut microbiome composition to central sensitisation and widespread pain conditions. Gut dysbiosis, which produces systemic inflammatory signalling, may worsen the neuroinflammatory environment relevant to fibromyalgia. Supporting microbiome diversity through a varied plant-rich diet, reducing ultra-processed food intake, and tracking microbiome composition over time is a practical approach with meaningful supporting evidence, even if the specific mechanisms in fibromyalgia are still being characterised.